Skip to content

Validity of the 6-Minute Pegboard and Ring Test in Parkinson's Patients

Investigation of the Validity and Reliability of the 6-Minute Pegboard and Ring Test in Parkinson's Patients for Upper Extremity Endurance Assessments

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06482502
Enrollment
34
Registered
2024-07-01
Start date
2024-05-20
Completion date
2025-12-31
Last updated
2025-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson, Validity, 6-Minute Pegboard and Ring Test

Brief summary

Tests used to assess upper extremity endurance in Parkinson's patients are limited. This study aimed to investigate whether the 6-Minute Pegboard and Ring Test (6-MPRT), which has been validated in many respiratory disease groups in previous studies, is an endurance assessment battery that can also be used in Parkinson's patients. 6-MPRT, Weight Lifting Test, and 30-Second Arm Curl Test will be applied in the assessments. Assessments will be made twice on the same day by two different evaluators, 1 hour apart. After the first evaluation, the patient will be called for the second time 2 days later, and the same procedure will be repeated.

Interventions

None listed

Sponsors

Emre Şenocak
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Hoehn & Yahr staging ≤3 points, * Individuals who have not undergone a rehabilitation program of at least 20 days in the last 6 months, * Those with full upper extremity shoulder flexion and abduction active joint range of motion.

Exclusion criteria

* Those with severe heart disease such as heart failure, cardiac arrhythmia, hypertension, * People with any orthopedic problem that will affect the upper extremity, * Having a secondary neurological disease diagnosis, * Having vision impairment that may affect measurement methods (not corrected by glasses), * Having a cognitive disease that may cause difficulty in following the researchers' commands, * Those who had changes in their medical use during the test (dose increase/decrease, drug change

Design outcomes

Primary

MeasureTime frameDescription
6-Minute Pegboard and Ring TestBaseline of the study (Assessor 1)The patient is in a sitting position. Opposite the patient are 4 metal rods located on a wooden table. Two of them are at shoulder level and the other two are 20 cm above shoulder level. During the test, the patient is asked to take the light rings at shoulder level with both hands at the same time and place them on the bars above. The higher the total number of rings carried indicates increased endurance.
30-Second Arm Curl TestBaseline of the studyThis test is performed with dumbbells. A 2.5-kilogram (5-pound) dumbbell is used for women and a 4-kilogram (8-pound) dumbbell for men. The test is performed in a sitting position. Patients are asked to repeat forearm flexion-supination and extension-pronation movements with the dumbbells in their hands as fast as they can for 30 seconds. The number of moves completed gives the total score.
Weight Lifting TestBaseline of the study (Assessor 2)This test is performed using dumbbells. Reference weights for women are 7 kg and for men are 10 kg. Patients will perform the test with each arm separately. The number of repetitions they can achieve is recorded. The test is performed standing.

Secondary

MeasureTime frameDescription
Demographic Data FormBaseline of the studyThis form was created by researchers and it consist of personal informations such as gender, age, body mass index, education, duration of disease, Unified Parkinson's Disease Rating Scale, Modified Hoehn & Yahr stage, using medicine, manual shoulder muscle strength

Countries

Turkey (Türkiye)

Contacts

Primary ContactEmre Şenocak, PhD
emre.senocak@windowslive.com+90 553 569 56 92

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026